Company Filing History:
Years Active: 1984-1989
Title: Masashi Awata: Innovator in Pharmaceutical Development
Introduction
Masashi Awata is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, Awata's work has garnered attention in the scientific community.
Latest Patents
Awata's latest patents include a physiologically active substance known as TPI. This compound has a complex formula and exhibits various biological activities, including bronchodilator and cardiac activity. It can be produced by culturing a microorganism from the genus Nodulisporium, specifically Nodulisporium sp. M5220 FERM P-8133. The compound also demonstrates inhibitory activity on cyclic-adenosine-3',5'-monophosphate phosphodiesterase. Another significant patent is for the antibiotic acmimycin, which is effective against both Gram-positive and Gram-negative bacteria. This antibiotic is produced by culturing the microorganism Streptomyces sp. AC4559 FERM P-6445.
Career Highlights
Masashi Awata is currently associated with Toyo Jozo Kabushiki Kaisha, where he continues to innovate in the pharmaceutical sector. His work has not only advanced scientific knowledge but also contributed to the development of new therapeutic agents.
Collaborations
Awata has collaborated with notable colleagues, including Masaki Takada and Hideo Sakakibara. These partnerships have facilitated the advancement of research and development in their respective fields.
Conclusion
Masashi Awata's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to advancing medical science and improving therapeutic options.